ReviewCureus2024

FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature.

Tejaswini Potlabathini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.